Justices from the right and left ask whether Congress needs to keep its promises.
The case revolves around a health law provision designed to help insurers recover some losses because they had an unusually high number of sick and expensive customers. Insurers complain that when Republican lawmakers discontinued funding the program, it was like “Lucy Van Pelt pulling the football away from Charlie Brown.”
It’s open enrollment season for health insurance. And choosing the best plan is tricky whether you have to buy insurance on your own or just figure out which plan to sign up for at work. Here’s what you need to know.
The annual accounting of national health spending is out. And the 2018 health bill for the U.S. was $3.6 trillion, consuming nearly a fifth of the nation’s economy. Meanwhile, Congress is nearing the end of the year without having finished either its annual spending bills or several other high-priority health items. Kimberly Leonard of the Washington Examiner, Joanne Kenen of Politico and Mary Agnes Carey of Kaiser Health News join KHN’s Julie Rovner to discuss this and more. Also, Rovner interviews KHN’s Markian Hawryluk about the latest KHN-NPR “Bill of the Month.”
A California law, which took effect in July 2017, protects consumers who use an in-network hospital or other facility from surprise bills when cared for by an out-of-network doctor. But physicians say the law has allowed insurers to shrink networks, limiting access to those doctors who have contracted with the patients’ insurance plans.
The pharmaceutical industry’s argument that capping drug prices would compromise drug innovation stands “on very shaky ground.”
Called “Ready, Set, PrEP,” the federal program will provide medication that can reduce the chances of getting AIDS to at-risk patients who don’t have insurance.
Polls show that health care is at the top of voters’ issues, but the polls also say Democrats, let alone other Americans, are not ready for “Medicare for All.”
Open enrollment for the Affordable Care Act’s marketplace plans is halfway over and, so far, the number of people signing up is down, but not dramatically. Meanwhile, Congress and President Donald Trump can’t seem to agree on what to do about teen vaping, drug prices or “surprise” medical bills. And Democrats lurch to the left on abortion. Paige Winfield Cunningham of The Washington Post, Kimberly Leonard of the Washington Examiner and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this and more health news.
The term “vast” sets a high bar.